triheptanoin has been researched along with Infarction, Middle Cerebral Artery in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berressem, D; Eckert, GP; Klein, J; Koch, K; Konietzka, J; Thinnes, A | 1 |
| Borges, K; Carrasco-Pozo, C; Hood, R; Manzanero, S; Pepperall, D; Spratt, NJ; Tan, KN; Warren, K | 1 |
| Klein, J; Koch, K; Schwarzkopf, TM | 1 |
3 other study(ies) available for triheptanoin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice.
Topics: 3-Hydroxybutyric Acid; Adrenergic beta-Antagonists; Animals; Brain; Brain Ischemia; Citric Acid; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Female; Gas Chromatography-Mass Spectrometry; Glucose; Infarction, Middle Cerebral Artery; Ketone Bodies; Liver; Mice; Microdialysis; Propranolol; Soybean Oil; Succinic Acid; Triglycerides | 2017 |
Heptanoate is neuroprotective in vitro but triheptanoin post-treatment did not protect against middle cerebral artery occlusion in rats.
Topics: Animals; Cells, Cultured; Heptanoates; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotection; Neuroprotective Agents; Rats; Rats, Wistar; Treatment Outcome; Triglycerides | 2018 |
Reduced severity of ischemic stroke and improvement of mitochondrial function after dietary treatment with the anaplerotic substance triheptanoin.
Topics: Adenosine Triphosphate; Animals; Body Weight; Brain; Brain Ischemia; Disease Models, Animal; Electron Transport; Fatty Acids; Female; Glucose; Glutamic Acid; Infarction, Middle Cerebral Artery; Matrix Metalloproteinases; Mice; Mitochondria; Motor Activity; Oxygen Consumption; Severity of Illness Index; Stroke; Triglycerides | 2015 |